Feasibility study of fertility preservation before neoadjuvant or adjuvant chemotherapy for breast cancer: PRESAGE
Latest Information Update: 11 Jan 2018
At a glance
- Drugs Tamoxifen (Primary) ; Follicle stimulating hormones
- Indications Breast cancer
- Focus Therapeutic Use
- Acronyms PRESAGE
- 11 Jan 2018 New trial record
- 09 Dec 2017 Results (n=50) assessing feasibility study of fertility preservation by controlled ovarian stimulation (COS) combined with Tamoxifene and oocyte +/- embryo cryopreservation before neoadjuvant (NAC) or adjuvant (AC) chemotherapy for breast cancer, were presented at the 40th Annual San Antonio Breast Cancer Symposium.